Bill, a 31-year-old engineer from Ohio, has struggled with health anxiety for the most of his life. That’s why, in late 2020, he purchased a Fitbit Sense. He reasoned that being able to obtain an ECG reading when he sensed something odd, such as heartburn or an accelerated heartbeat, would convince him that he was healthy. Bill, on the other hand, became even more concerned after receiving inconclusive ECG results on the Fitbit Sense.
An inconclusive result does not imply a health problem; it simply means the gadget was unable to obtain an accurate reading. Fitbit explains on its website that this can happen if there is too much movement during the scan or if the wearer’s heart rate is too high or low. Bill, on the other hand, was unaware of this when, due to his worry around springtime last year, he was taking up to 20 ECGs per day.
That answer is starting to come together, based on interactions with medical experts, analysts, and officials at the firms behind some of these medicines. The industry has entered its awkward adolescent era, if you regard the early days of step counting and simple activity logging as the infancy of consumer health tracking.